Loading clinical trials...
Loading clinical trials...
NBI-34060 is an investigational (research) medication being studied in people with insomnia. The current study is designed to evaluate how people, who experience a nighttime awakening with difficulty ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Neurocrine Biosciences
NCT06109363 · Insomnia, Sleep Disturbance
NCT07091149 · Insomnia
NCT06843187 · Major Depressive Disorder(MDD), Insomnia Comorbid to Psychiatric Disorder
NCT07216261 · Chronic Insomnia
NCT04896775 · Insomnia, Dementia
Sleep Disorders Center of Georgia
Atlanta, Georgia
Clinilabs, Inc.
New York, New York
Community Research
Cincinnati, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions